Bristol-Myers Squibb Rights
CELG.RT
20 hedge funds and large institutions have $88K invested in Bristol-Myers Squibb Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
20% less funds holding
Funds holding: 25 → 20 (-5)
55% less capital invested
Capital invested by funds: $194K → $88K (-$106K)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$12.2K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$301 |
| 3 |
Morgan Stanley
New York
|
+$21 |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Redpoint Investment Management
Sydney, NSW,
Australia
|
-$15K |
| 2 |
SAM
Selway Asset Management
|
-$9K |
| 3 |
CRIG
Charter Research & Investment Group
Southport,
Connecticut
|
-$8K |
| 4 |
DAM
Deltec Asset Management
New York
|
-$7K |
| 5 |
GGI
Godsey & Gibb Inc
Richmond,
Virginia
|
-$7K |
CELG.RT Hedge Fund Activity: Q1 2021 in Review
20 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q1 2021, worth a combined $88K — down 55% from $194K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CELG.RT and 2 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $12.2K. The largest seller was Redpoint Investment Management, exiting entirely with an estimated $15K sold.
- 20 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q1 2021, down from 25 in Q4 2020.
- Funds reported $88K of Bristol-Myers Squibb Rights stock for Q1 2021, down 55% quarter-over-quarter.
- 2 funds opened new Bristol-Myers Squibb Rights positions in Q1 2021 and 7 closed out, a net change of -5 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q1 2021 was Virtu Financial, an estimated $12.2K added.
- The largest Bristol-Myers Squibb Rights seller in Q1 2021 was Redpoint Investment Management, an estimated $15K sold.
Based on aggregated 13F filings for Q1 2021.